Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo

por Torchia, James A., Tavares, Alexander H., Carstensen, Laura S., Chen, Da-Yuan, Huang, Jessie, Xiao, Tianshu, Mukherjee, Sonia, Reeves, Patrick M., Tu, Hua, Sluder, Ann E., Chen, Bing, Kotton, Darrell N., Bowen, Richard A., Saeed, Mohsan, Poznansky, Mark C., Freeman, Gordon J.
Publicado 2022

Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19

por Gregory, David J., Vannier, Augustin, Duey, Akiro H., Roady, Tyler J., Dzeng, Richard K., Pavlovic, Maia N., Chapin, Michael H., Mukherjee, Sonia, Wilmot, Hannah, Chronos, Nic, Charles, Richelle C., Ryan, Edward T., LaRocque, Regina C., Miller, Tyler E., Garcia-Beltran, Wilfredo F., Thierauf, Julia C., Iafrate, A. John, Mullenbrock, Steven, Stump, Mark D., Wetzel, Randall K., Polakiewicz, Roberto D., Naranbhai, Vivek, Poznansky, Mark C.
Publicado 2022